Sorafenib and NK cells modulate multiple signaling pathways in HCC, including Ras/Raf/MEK/ERK, NF-κB, PI3K/AKT/mTOR, Wnt/β-catenin and JAK/STAT pathway. This evidence concerns the gene AKT1 and hepatocellular carcinoma.